RxDoctor Payments Data

Brett Oestreich, MD

Interventional Cardiology · Saint Paul, MNNPI 1023384211

Payments from drug & device makers

What this record shows

This record is dominated by grants: $18,000 of the $25,939 with a category attached, or 69.4%. Medtronic accounts for 77.6% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $19,972 and has fallen 94.5% since, to $1,094 in 2025.

$25,939in general payments, 2019–2025

Across 131 payments — averaging $198.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$20K
  • Edwards Lifesciences$4K
  • Abbott$977
  • Boston Scientific$307
  • Teleflex LLC$242
  • Shockwave Medical, Inc$240
  • plus $25 from 1 others

What the payments were for

  • Grants$18,00069%
  • Travel & lodging$1,3785%
  • Food & beverage$6,39025%
  • Education$1721%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,939 in reported general payments places this provider in the 80th percentile of 84 interventional cardiology providers in Minnesota.

See all interventional cardiology providers in Minnesota

Medicare billing

Part B allowed, 2024
$88,518
Medicare patients
1,259
Services billed
1,694

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban26$28,845
Atorvastatin Calcium36$465
ClopidogrelClopidogrel Bisulfate32$393
Losartan Potassium17$177
Metoprolol Succinate14$109
Methylprednisolone11$79

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Saint Paul

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →